Vimarsana
Biggest News Aggregation in the World

Mulesoft Apis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mulesoft Apis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mulesoft Apis Today - Breaking & Trending Today

Salesforce com : Announces General Availability of Einstein Copilot Along with New Einstein Copilot Actions for Sellers and Tools for Driving Enterprise AI Adoption - Vimarsana News

Salesforce com : Announces General Availability of Einstein Copilot Along with New Einstein Copilot Actions for Sellers and Tools for Driving Enterprise AI Adoption

Einstein Copilot, Salesforce's conversational AI assistant, is now generally available with new out-of-the-box actions for driving sales productivity New Copilot...

TrailblazerDX 2024 - in review - Vimarsana News

TrailblazerDX 2024 - in review

Casting an end-of-month eye over the announcements from the Salesforce developer event.

TrailblazerDX - delivering actionable analytics to advisors at RBC Wealth Management - Vimarsana News

TrailblazerDX - delivering actionable analytics to advisors at RBC Wealth Management

At RBC Wealth Management, a dedicated Center of Excellence works with Salesforce admins to design analytics dashboards that help financial advisors engage...

Tech gives vaccine programs a shot in the arm as Qualtrics study highlights the importance of user experience in mass take-up - Vimarsana News

Tech gives vaccine programs a shot in the arm as Qualtrics study highlights the importance of user experience in mass take-up

Read later Audio version Summary: Vaccinations are the key to getting to the so-called 'new normal'. Enterprise tech is playing its role in getting the jabs to people's arms, but there's a need to focus on experience-based messaging to counter hesitancy in key communities. (Pixabay ) The emergence of COVID-19 vaccines is the good news that millions around the world have waited to hear for over a year. But there are those who still harbor (vocal) doubts about their rollout, doubts that need to be overcome if successful mass-vaccination is to be achieved.  A recent study by Kantar Public, pol...